S&P 500   4,207.27 (-0.07%)
DOW   33,336.67 (+0.08%)
QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
S&P 500   4,207.27 (-0.07%)
DOW   33,336.67 (+0.08%)
QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
S&P 500   4,207.27 (-0.07%)
DOW   33,336.67 (+0.08%)
QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
S&P 500   4,207.27 (-0.07%)
DOW   33,336.67 (+0.08%)
QQQ   324.08 (-0.57%)
AAPL   168.49 (-0.44%)
MSFT   287.02 (-0.74%)
META   177.49 (-0.48%)
GOOGL   118.84 (-0.72%)
AMZN   140.64 (-1.44%)
TSLA   859.89 (-2.62%)
NVDA   179.42 (-0.86%)
NIO   20.82 (+3.84%)
BABA   94.87 (+2.64%)
AMD   98.12 (-0.94%)
MU   62.32 (+1.50%)
T   18.04 (+0.17%)
CGC   3.15 (-4.26%)
GE   78.90 (+2.28%)
F   15.83 (+2.13%)
DIS   117.69 (+4.68%)
AMC   25.46 (+7.56%)
PYPL   99.11 (+0.20%)
PFE   48.29 (-3.32%)
NFLX   242.70 (-0.58%)
NYSE:ITGR

Integer - ITGR Stock Forecast, Price & News

$73.47
+1.02 (+1.41%)
(As of 08/11/2022 04:35 PM ET)
Add
Compare
Today's Range
$73.33
$74.36
50-Day Range
$65.87
$80.14
52-Week Range
$64.95
$100.71
Volume
119,929 shs
Average Volume
171,473 shs
Market Capitalization
$2.43 billion
P/E Ratio
31.53
Dividend Yield
N/A
Price Target
$101.00

Integer MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
36.9% Upside
$101.00 Price Target
Short Interest
Bearish
2.30% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
12.79%
From $4.30 to $4.85 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.26 out of 5 stars

Medical Sector

432nd out of 1,112 stocks

Miscellaneous Electrical Machinery, Equipment, & Supplies Industry

8th out of 23 stocks

ITGR stock logo

About Integer (NYSE:ITGR) Stock

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Integer Price Performance

Shares of ITGR traded up $1.19 during trading hours on Thursday, reaching $73.64. The company had a trading volume of 5,056 shares, compared to its average volume of 145,642. The company has a current ratio of 2.70, a quick ratio of 1.71 and a debt-to-equity ratio of 0.68. The firm has a 50 day simple moving average of $70.74 and a 200-day simple moving average of $76.41. Integer has a 12-month low of $64.95 and a 12-month high of $100.71. The company has a market capitalization of $2.44 billion, a price-to-earnings ratio of 31.09 and a beta of 1.21.

Integer (NYSE:ITGR - Get Rating) last announced its quarterly earnings results on Thursday, July 28th. The medical equipment provider reported $1.04 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.18 by ($0.14). Integer had a net margin of 6.10% and a return on equity of 9.50%. The business had revenue of $350.10 million during the quarter, compared to analysts' expectations of $343.57 million. During the same period last year, the company earned $1.07 EPS. The firm's revenue for the quarter was up 12.2% on a year-over-year basis. Research analysts expect that Integer will post 4.3 earnings per share for the current year.

Analyst Ratings Changes

Several brokerages have weighed in on ITGR. KeyCorp reduced their price objective on Integer from $109.00 to $97.00 and set an "overweight" rating on the stock in a research note on Friday, July 29th. StockNews.com downgraded shares of Integer from a "buy" rating to a "hold" rating in a report on Monday, April 25th. Finally, TheStreet downgraded shares of Integer from a "b-" rating to a "c+" rating in a research note on Friday, May 13th.

Receive ITGR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Integer and its competitors with MarketBeat's FREE daily newsletter.

ITGR Stock News Headlines

KeyCorp Lowers Integer (NYSE:ITGR) Price Target to $97.00
Contrasting SES AI (NYSE:SES) and Integer (NYSE:ITGR)
See More Headlines
Receive ITGR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Integer and its competitors with MarketBeat's FREE daily newsletter.

ITGR Company Calendar

Last Earnings
7/28/2022
Today
8/11/2022
Next Earnings (Estimated)
10/27/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Miscellaneous electrical machinery, equipment, & supplies
Sub-Industry
Health Care Equipment
Sector
Medical
Previous Symbol
NASDAQ:ITGR
CUSIP
39153L10
Employees
9,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$101.00
High Stock Price Forecast
$105.00
Low Stock Price Forecast
$97.00
Forecasted Upside/Downside
+37.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$96.81 million
Pretax Margin
6.54%

Debt

Sales & Book Value

Annual Sales
$1.22 billion
Cash Flow
$7.04 per share
Book Value
$41.16 per share

Miscellaneous

Free Float
32,457,000
Market Cap
$2.43 billion
Optionable
Optionable
Beta
1.21

Key Executives

  • Mr. Joseph W. Dziedzic (Age 54)
    Pres, CEO & Director
    Comp: $1.92M
  • Mr. Jason K. Garland (Age 48)
    Exec. VP & CFO
    Comp: $792.28k
  • Ms. Jennifer M. Bolt (Age 53)
    Exec. VP of Global Operations & ESG
    Comp: $615.84k
  • Mr. Payman Khales (Age 52)
    Pres of Cardio & Vascular
    Comp: $645.16k
  • Mr. Joel D. Becker (Age 54)
    Pres of Cardiac Rhythm Management & Neuromodulation
    Comp: $637.21k
  • Mr. Anthony W. Borowicz (Age 65)
    Sr. VP of Investor Relations
  • Mr. McAlister C. Marshall II (Age 52)
    Sr. VP, Gen. Counsel, Chief Ethics & Compliance Officer and Corp. Sec.
  • Mr. Kirk K. Thor (Age 58)
    Exec. VP & Chief HR Officer
  • Mr. Carter Houghton (Age 53)
    Pres of Electrochem & Power Solutions
  • Ms. Margaret Carthy (Age 58)
    Sr. VP of Quality & Regulatory Affairs













ITGR Stock - Frequently Asked Questions

Should I buy or sell Integer stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Integer in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ITGR shares.
View ITGR analyst ratings
or view top-rated stocks.

What is Integer's stock price forecast for 2022?

2 Wall Street analysts have issued 1 year price objectives for Integer's shares. Their ITGR share price forecasts range from $97.00 to $105.00. On average, they expect the company's stock price to reach $101.00 in the next year. This suggests a possible upside of 36.9% from the stock's current price.
View analysts price targets for ITGR
or view top-rated stocks among Wall Street analysts.

How have ITGR shares performed in 2022?

Integer's stock was trading at $85.59 on January 1st, 2022. Since then, ITGR stock has decreased by 13.8% and is now trading at $73.75.
View the best growth stocks for 2022 here
.

When is Integer's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our ITGR earnings forecast
.

How were Integer's earnings last quarter?

Integer Holdings Co. (NYSE:ITGR) posted its earnings results on Thursday, July, 28th. The medical equipment provider reported $1.04 EPS for the quarter, missing the consensus estimate of $1.18 by $0.14. The medical equipment provider had revenue of $350.10 million for the quarter, compared to analysts' expectations of $343.57 million. Integer had a trailing twelve-month return on equity of 9.50% and a net margin of 6.10%. The business's quarterly revenue was up 12.2% on a year-over-year basis. During the same quarter last year, the business earned $1.07 EPS.

What guidance has Integer issued on next quarter's earnings?

Integer issued an update on its FY 2022 earnings guidance on Thursday, August, 4th. The company provided earnings per share (EPS) guidance of $4.20-$4.50 for the period, compared to the consensus estimate of $4.45. The company issued revenue guidance of $1.37 billion-$1.40 billion, compared to the consensus revenue estimate of $1.36 billion.

What is Joseph Dziedzic's approval rating as Integer's CEO?

40 employees have rated Integer Chief Executive Officer Joseph Dziedzic on Glassdoor.com. Joseph Dziedzic has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Integer own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Integer investors own include Abbott Laboratories (ABT), Pfizer (PFE), Procter & Gamble (PG), Gilead Sciences (GILD), Coca-Cola (KO), AT&T (T), AbbVie (ABBV), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and General Mills (GIS).

What is Integer's stock symbol?

Integer trades on the New York Stock Exchange (NYSE) under the ticker symbol "ITGR."

Who are Integer's major shareholders?

Integer's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Victory Capital Management Inc. (2.62%), abrdn plc (2.20%), Allspring Global Investments Holdings LLC (0.96%), Emerald Advisers LLC (0.90%), Tributary Capital Management LLC (0.81%) and Emerald Mutual Fund Advisers Trust (0.74%). Insiders that own company stock include Anthony W Borowicz, Bill R Sanford, Bill R Sanford, Carter Houghton, Jean M Hobby, Joseph F Flanagan, Joseph W Dziedzic, Pamela G Bailey and Peter H Soderberg.
View institutional ownership trends
.

How do I buy shares of Integer?

Shares of ITGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Integer's stock price today?

One share of ITGR stock can currently be purchased for approximately $73.75.

How much money does Integer make?

Integer (NYSE:ITGR) has a market capitalization of $2.44 billion and generates $1.22 billion in revenue each year. The medical equipment provider earns $96.81 million in net income (profit) each year or $2.33 on an earnings per share basis.

How many employees does Integer have?

The company employs 9,000 workers across the globe.

How can I contact Integer?

Integer's mailing address is 5830 Granite Parkway Suite 1150, Plano TX, 75024. The official website for the company is www.integer.net. The medical equipment provider can be reached via phone at (214) 618-5243, via email at ir@integer.net, or via fax at 716-759-5654.

This page (NYSE:ITGR) was last updated on 8/11/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.